Continuous Blood Flow Thrombosis
Continuous Blood Flow Thrombosis - Related Videos
05:09
Long-Term Continuous Measurement of Renal Blood Flow in Conscious Rats
0 Views •
Cited by 3 •
2022
The present protocol describes a long-term continuous measurement of renal blood flow in conscious rats and simultaneously recording blood pressure with implanted catheters (fluid-filled or by telemetry).
10:37
Ferric Chloride-induced Murine Thrombosis Models
0 Views •
Cited by 56 •
2016
We report a refined procedure of the ferric chloride (FeCl3)-induced thrombosis models on carotid and mesenteric artery as well as vein, characterized efficiently using intravital microscopy to monitor time to occlusive thrombi formation.
03:38
Developing a Cerebral Blood Flow Atlas for Blood Flow Mapping
0 Views •
2025
Source: Tan, Z., et al., Construction and Application of Cerebral Functional Region-Based Cerebral Blood Flow Atlas Using Magnetic Resonance Imaging-Arterial Spin Labeling. J. Vis. Exp. (2024).This video demonstrates the method to construct a cerebral blood flow atlas by integrating magnetic resonance imaging or MRI-arterial spin labeling data with segmented brain regions, visualizing blood flow patterns, and quantifying flow levels across functional areas.
10:25
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
0 Views •
Cited by 9 •
2016
Platelet transfusion and hemostasis was modeled using blood reconstitution and microfluidic flow chambers to investigate the function of blood banking platelets. The data demonstrate the consequences of platelet storage lesion on hemostasis, in vitro.
01:29
Blood Flow
0 Views •
2025
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow. Slow...
FAQs
The process is driven by several linked responses rather than a single trigger. Contact between blood and an artificial surface can promote platelet activation, while coagulation adds another pathway toward thrombus formation. Considering both mechanisms helps explain why device-associated clotting may continue even when circulation remains active.
Flow conditions influence how biological and material interactions unfold. Disturbed flow can create an environment associated with thrombus formation, while high-shear flow can also promote it. Simply maintaining blood movement therefore does not eliminate risk; evaluating the flow pattern is important when assessing pumps, oxygenators, or other blood-contacting systems.
Continuous Blood Flow Thrombosis highlights that ongoing circulation does not by itself prevent clot formation. The outcome reflects combined effects from blood-material contact, platelet activation, coagulation, and flow conditions. This systems-level view is useful because modifying device surfaces or flow design may influence the overall thrombosis risk rather than only one isolated mechanism.
Studying Continuous Blood Flow Thrombosis provides a way to evaluate technologies that keep blood moving through cardiovascular devices. Ventricular assist devices, pumps, oxygenators, and extracorporeal circuits are specifically relevant settings. The assessment can identify thrombosis concerns that may impair device function or create a risk of embolization.
An evaluation can center on four connected factors: the blood-contacting material, platelet activation, coagulation, and the device’s flow environment. Researchers can then consider whether thrombus formation could compromise function or lead to embolization. This framework links mechanistic observations to performance and safety questions involving cardiovascular devices and extracorporeal circuits.
Findings can guide two complementary design goals: reducing blood-material interactions and improving flow design. They also inform anticoagulation strategies, which must address thrombosis while limiting bleeding risk. This balance is central to developing safer ventricular assist devices, pumps, oxygenators, and extracorporeal circuits without treating clot prevention as the only design objective.